| | | | |
CUSIP No. 773122106 | | Schedule 13D | | Page 7 |
EXPLANATORY NOTE
This Amendment No. 1 (this “Amendment”) to the statement on Schedule 13D originally filed by the Reporting Persons on September 7, 2021 (as amended from time to time, the “Schedule 13D”) relates to shares of common stock, par value $0.0001 per share (the “Common Stock”), of Rocket Lab USA, Inc., a Delaware corporation (the “Company”). Unless otherwise indicated, each capitalized term used but not defined in this Amendment shall have the meaning assigned to such term in the Schedule 13D. Except as otherwise specifically amended in this Amendment, items in the Schedule 13D remain unchanged.
ITEM 4. | PURPOSE OF TRANSACTION |
Item 4 of the Schedule 13D is hereby amended and supplemented by adding the following:
On September 11, 2023, the Trust sold 3,600,000 shares of Common Stock pursuant to a block trade with Goldman Sachs & Co. LLC (“Goldman Sachs”) at a price of $5.62 per share (the “Block Trade”).
ITEM 5. | INTEREST IN SECURITIES OF THE ISSUER. |
Item 5(a) – (c) of the Schedule 13D is hereby amended and restated as follows:
(a) See Rows 11 and 13 for each Reporting Person. The percentage listed in Row 13 for each Reporting Person was calculated based on 483,326,614 shares of Common Stock, outstanding as of August 3, 2023, as set forth in the Company’s Quarterly Report on Form 10-Q filed with the Commission on August 8, 2023.
(b) See Rows 7, 8, 9, and 10 for each Reporting Person.
(c) The information set forth in Item 4 of this Amendment is incorporated by reference herein. Otherwise, the Reporting Persons have not effected any transactions in the Common Stock of the Company during the past 60 days.
ITEM 6. | CONTRACTS, ARRANGEMENTS, UNDERSTANDINGS OR RELATIONSHIPS WITH RESPECT TO SECURITIES OF THE ISSUER. |
Item 6 of the Schedule 13D is hereby amended and supplemented by adding the following:
In connection with the Block Trade, Peter Beck agreed orally with Goldman Sachs that neither he nor the Trust will offer or sell any additional shares of Common Stock in 2023 and has no present intention to sell additional shares at this time.
The information set forth in Item 4 of this Amendment is incorporated by reference into this Item 6.